Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

P-BEAM: Biosimilars Educational Advanced Masterclass for Pharmacists

5 - 6 Sep 2019
Hilton Zurich Airport, Zurich, Switzerland
The role of the pharmacist in supporting multi-disciplinary education
Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands
The role of the pharmacist in supporting multi-disciplinary education ( Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands )
8 Oct 2019
Effective communication about biosimilars
Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands
Effective communication about biosimilars ( Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands )
8 Oct 2019
Practical guidance on the assessment of biosimilar monoclonal antibodies: A phar...
Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands
Practical guidance on the assessment of biosimilar monoclonal antibodies: A pharmacist's perspective ( Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands )
8 Oct 2019
Assessing biosimilars in the real world setting
Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands
Assessing biosimilars in the real world setting ( Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands )
8 Oct 2019
Realising the potential of biosimilars
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Realising the potential of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Comment: Supporting a sustainable biosimilar solution
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Supporting a sustainable biosimilar solution ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Comment: Use of biosimilar monoclonal antibodies in the clinic
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Use of biosimilar monoclonal antibodies in the clinic ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Comment: Critical quality attributes of biosimilars
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Critical quality attributes of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Comment: Immunogenicity of biosimilars
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Immunogenicity of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Successful implementation of biosimilars through effective communication
Dr Pauline Leonard - The Whittington Hospital, London, UK
Successful implementation of biosimilars through effective communication ( Dr Pauline Leonard - The Whittington Hospital, London, UK )
25 Sep 2019
Practical considerations for introducing biosimilars
Simon Cheesman - University College Hospital, London, UK
Practical considerations for introducing biosimilars ( Simon Cheesman - University College Hospital, London, UK )
25 Sep 2019
How real-world data generation can assist biosimilar implementation
Simon Cheesman - University College Hospital, London, UK
How real-world data generation can assist biosimilar implementation ( Simon Cheesman - University College Hospital, London, UK )
25 Sep 2019
Regulatory principles for biosimilar medicines
Prof Paul Declerck - KU Leuven, Leuven, Belgium
Regulatory principles for biosimilar medicines ( Prof Paul Declerck - KU Leuven, Leuven, Belgium )
25 Sep 2019
Biologics utilisation and its efficiency through a hospital pharmacy centralised...
Jose Feio - University of Coimbra, Coimbra, Portugal
Biologics utilisation and its efficiency through a hospital pharmacy centralised management system ( Jose Feio - University of Coimbra, Coimbra, Portugal )
25 Sep 2019
The science of biosimilarity: Immunogenicity
Prof João Gonçalves - University of Lisbon, Lisbon, Portugal
The science of biosimilarity: Immunogenicity ( Prof João Gonçalves - University of Lisbon, Lisbon, Portugal )
25 Sep 2019
Introduction of the biosimilar trastuzumab and its impact on patients and servic...
Geoff Saunders - The Christie NHS Foundation Trust, Manchester, UK
Introduction of the biosimilar trastuzumab and its impact on patients and services ( Geoff Saunders - The Christie NHS Foundation Trust, Manchester, UK )
25 Sep 2019
Practical guidance on the assessment of biosimilar monoclonal antibodies: A phys...
Prof Diana Lüftner - Charité University Hospital, Berlin, Germany
Practical guidance on the assessment of biosimilar monoclonal antibodies: A physician's perspective ( Prof Diana Lüftner - Charité University Hospital, Berlin, Germany )
25 Sep 2019